Semaglutide Significantly Improves Gut, Heart, and Metabolism in Diet-Induced Obesity

Obesity, often induced by chronic consumption of high-calorie, "cafeteria" style diets, represents a formidable global health crisis, frequently progressing to severe complications such as metabolic syndrome, type 2 diabetes, and cardiovascular disease. These complex conditions are intricately linked through a multifaceted gut-heart-metabolic axis, where dysfunction in one component can profoundly exacerbate pathologies in others, creating a vicious cycle of decline. Despite the well-established efficacy of Semaglutide in promoting substantial weight loss and improving glycemic control, the precise mechanisms and extent to which it restores structural and metabolic homeostasis across this critical, interconnected axis in models of diet-induced obesity have remained largely unexplored.